Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
Abstract Background Hepatoblastoma, a leading primary hepatic malignant tumor in children, is originated from primitive hepatic stem cells. We aimed to elucidate the relationships between the histological distribution of β-catenin and hepatic stem cell markers with the clinical outcomes of hepatobla...
Main Authors: | Jia-Feng Wu, Hsiu-Hao Chang, Meng-Yao Lu, Shiann-Tarng Jou, Kai-Chi Chang, Yen-Hsuan Ni, Mei-Hwei Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12929-017-0369-1 |
Similar Items
-
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
by: Wei-Yun Hsu, et al.
Published: (2020-08-01) -
Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma
by: Wei-Ju Huang, et al.
Published: (2017-07-01) -
Summary of biological research on hepatoblastoma: a scoping review
by: Huan-sheng Wang, et al.
Published: (2024-02-01) -
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
by: Caroline Gest, et al.
Published: (2023-05-01) -
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
by: Ruhi Gulati, et al.
Published: (2022-12-01)